Try our Advanced Search for more refined results

July 02, 2018

Genentech, Inc. v. Eli Lilly and Company

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 23, 2021

    Eli Lilly Loses $10M Fee Bid Over Genentech's Dropped IP Suit

    A California federal judge on Tuesday rejected Eli Lilly & Co.'s bid for $10 million in attorney fees alleging Genentech Inc. dragged out litigation before dropping its patent suit over a psoriasis drug while noting Genentech unreasonably failed to tell the USPTO about a Federal Circuit decision weakening its claim to patent protection. 

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login